Steroid Therapy in Community-Acquired Pneumonia: An Updated Systematic Review and Meta-Analysis.
Bijeta Keisham, Sanchit Duhan, Divyansh Bajaj et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis evaluated the impact of corticosteroid therapy on mortality and morbidity in 5,866 adults with community-acquired pneumonia (CAP). While corticosteroids did not significantly reduce overall mortality (RR 0.84), they were associated with a significant reduction in mortality for severe CAP patients (RR 0.73). Additionally, corticosteroids decreased hospital length of stay by an average of 2.13 days.
Key findings
- Corticosteroids reduced mortality in severe CAP patients (RR 0.73; p = 0.01).
- No mortality benefit was observed in less severe CAP (RR 1.14; p = 0.31).
- Hospital length of stay decreased by an average of 2.13 days with corticosteroids (MD -2.13 days; p < 0.00001).
- Corticosteroids did not significantly increase the need for mechanical ventilation (RR 0.57; p = 0.10).
Why it matters
Understanding the role of corticosteroids in treating community-acquired pneumonia is crucial for optimizing patient outcomes, particularly in severe cases where mortality and hospitalization duration can be significantly impacted.